Inuvo is trading 6.2% down at $0.48, with no confirmed company-specific catalyst identified for the October 12 decline.
- Inuvo’s investor-relations calendar lists its latest results call on August 11 and a September conference, with no October 12 announcement shown.
- An October 12 Zacks article revisited weak second-quarter results, including a 67% year-over-year revenue decline, but did not link them to the day’s price move.
- Major indexes were nearly flat, so broad-market weakness does not clearly explain the decline.